How much funding has Terns Pharmaceuticals raised?

Terns Pharmaceuticals has raised $167.0M in total funding, most recently a Series C round.

Who are Terns Pharmaceuticals's investors?

Terns Pharmaceuticals's investors include Deerfield Management, Vivo Capital, OrbiMed.

When was Terns Pharmaceuticals founded?

Terns Pharmaceuticals was founded in 2016.

Where is Terns Pharmaceuticals headquartered?

Terns Pharmaceuticals is headquartered in Foster City, California, United States.

What industry is Terns Pharmaceuticals in?

Terns Pharmaceuticals operates in biotechnology, Healthcare.

How many employees does Terns Pharmaceuticals have?

Terns Pharmaceuticals has 51-200 employees.

Terns Pharmaceuticals

IPO

Home - Terns Pharma

Public · Foster City, United States · Founded 2016 · $167.0M raised

biotechnology

Healthcare

Headquarters: Foster City, California
Employees: 51–200
Founded: 2016
Business Model: B2B
Website: ternspharma.com

Total Funding: $167.0M
Last Round: $87.0M Series CJan 2021
Rounds: 2
Type: Public

About

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel therapies for metabolic diseases, including obesity, MASH (metabolic dysfunction-associated steatohepatitis), and related conditions. Founded in 2016, the company's pipeline includes THR-β agonist, GLP-1 receptor agonist, and other complementary mechanisms targeting cardio-metabolic disease.

Summary

Terns Pharmaceuticals is a biotechnology company based in Foster City, United States, founded in 2016. It has raised $167.0M in total across 2 rounds, most recently a $87.0M Series C round in Jan 2021. Investors include Deerfield Management, Vivo Capital and OrbiMed.

LinkedIn X (Twitter)